Search

Search Constraints

You searched for: Author/Creator Coliat, Pierre

Search Results

1. A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53. (January 2019)

2. Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects (Small 12/2023). Issue 12 (22nd March 2023)

3. Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects. Issue 12 (1st January 2023)

4. Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature. Issue 9 (September 2015)

5. Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature. Issue 9 (September 2015)

7. TROIKA‐1: A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU‐Herceptin® and US‐Herceptin® in healthy male subjects. Issue 4 (26th July 2021)